The Rohrabacher-Farr amendment: What You Need to Know
September 13th, 2017
Policy, Top News
None of the funds made available in this Act to the Department of Justice may be used, with respect to the States of Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, Oregon, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Washington, and Wisconsin, to prevent such States from implementing their own State laws that authorize the use, distribution, possession, or cultivation of medical marijuana.
~ The Rohrabacher-Farr Amendment, December 2014
The Rohrabacher-Farr Amendment, first called the Hinchey-Rohrabacher Amendment, was introduced in 2003, and it set prohibitive limits on the Federal Justice Department’s budget concerning interference with States’ rights to medical programs they’ve developed. Original sponsors of the bill included Maurice Hinchey, Dana Rohrabacher, and Sam Farr. After six failed votes between its introduction, the amendment passed as The Rohrabacher-Farr Amendment in December ’14 as part of a spending bill. Key aspects of the amendment include that it must be renewed annually, that it had a rocky implementation with interference by the Justice Department and finally, that it won a strong victory in 2015, tying the hands of AG Jeff Sessions and his Justice Department during the current Presidency.
Despite the protections that the Rohrabacher-Farr Amendment provide, one critical flaw is that the amendment must be renewed yearly. Given mobilized forces in Congress like the Marijuana Caucus paired with a surging public favor for cannabis, ensuring that this deadline is met with strong congressional support looks favorable in the future. Nonetheless, this loophole exists, and could jeopardize the amendment should prohibitionist interests in Congress find a way to delay its renewal at the end of the fiscal year.
As mentioned, The Rohrabacher-Farr Amendment was voted on six times before passing, and that was just the beginning of the challenge. In April 2015, the Department of Justice announced their interpretation of the amendment and claimed that they still had the authority to prosecute individuals who were compliant with statewide legalization for medical or recreational purposes. Both Farr and Rohrabacher criticized the interpretation, and in October 2015, US District Judge Charles Breyer ruled on side with the original intent of the amendment to provide protection to state-legal cannabis programs. His remarks on the Justice Department’s actions were strong, calling them, “counterintuitive and opportunistic“. Further solidifying the amendment’s place, in April 2016, the Justice Department withdrew their repeal of Judge Breyer’s decision. Later in 2016, the Ninth Circuit Court of Appeals rejected the DOJ interpretation in August. This decision, made unanimously by a three-judge panel is binding and not likely to be challenged in any of the nine western states in the Ninth Circuit.
With these two major 2016 decisions standing in favor of the Rohrabacher-Farr Amendment’s influence over the Justice Department, Attorney General Jeff Sessions has no means to “crack down” on the cannabis industry even if that’s exactly what he wants. Criminal investigations into state-legal dispensaries on a Federal level have led to raids in the past, and they will in the future as well: The Rohrabacher-Farr Amendment does not legalize cannabis Federally, it simply keeps money out of the hands of people who would seek to tear down a “budding” industry. With the continued momentum of popular vote and outcry, The Rohrabacher-Farr Amendment will be steadily renewed until Federal legalization comes to pass.
Trump added a signed statement on May 5, 2017 to the medical cannabis provision of the amendment stating,
“Division B, section 537 provides that the Department of Justice may not use any funds to prevent implementation of medical marijuana laws by various States and territories. I will treat this provision consistently with my constitutional responsibility to take care that the laws be faithfully executed.”
As of September 2017, he has still not infringed on the sanctity of the Rohrbacher-Farr Amendment nor the Cole Memo.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.